$ 226.39 <%= Resources.Global.txtDown %>
Updated 17/04/2019
Change % -0.35% Stock price decreasing
Change -0.79 Stock price decreasing
Volume 2,026,564
High $ 227.80
Low $ 221.53
Open $ 227.28
ISIN
Prev close $ 227.18
# of shares 196.71M
Market cap 44,533M USD
Intraday

Market closed
Biogen Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  226.39 -3.5% Stock price decreasing -0.2% Stock price decreasing -32.9% Stock price decreasing -29.3% Stock price decreasing -13.9% Stock price decreasing
Powered by TradingView

News about Biogen Inc

  • English
  • Regulatory news
12 Apr
 
26 Mar
 
21 Mar
 
12 Mar
 
04 Mar
 
28 Feb
 
25 Feb
 
25 Feb
 
04 Jan
 
04 Jan
 

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 73.92 -5.2% Stock price decreasing -7.7% Stock price decreasing 3.5% Stock price increasing 9.4% Stock price increasing 24.9% Stock price increasing 2.2% Stock price increasing
 
Bristol-Myers Squibb Company 45.52 -0.1% Stock price decreasing -7.0% Stock price decreasing -9.2% Stock price decreasing -16.2% Stock price decreasing -11.0% Stock price decreasing -12.4% Stock price decreasing
 
Johnson & Johnson 137.52 1.1% Stock price increasing -0.4% Stock price decreasing 5.2% Stock price increasing -1.1% Stock price decreasing 8.6% Stock price increasing 6.6% Stock price increasing
 
Pfizer Inc 39.38 -5.6% Stock price decreasing -7.0% Stock price decreasing -7.4% Stock price decreasing -11.5% Stock price decreasing 7.5% Stock price increasing -9.8% Stock price decreasing
 
Amgen Inc 177.47 -7.3% Stock price decreasing -7.5% Stock price decreasing -13.0% Stock price decreasing -12.1% Stock price decreasing 3.4% Stock price increasing -8.8% Stock price decreasing
 
Novartis AG 76.41 -4.8% Stock price decreasing -18.4% Stock price decreasing -14.1% Stock price decreasing -12.4% Stock price decreasing -1.9% Stock price decreasing -11.0% Stock price decreasing
 
GlaxoSmithKline PLC 39.85 -1.8% Stock price decreasing -3.4% Stock price decreasing 2.0% Stock price increasing -2.5% Stock price decreasing -0.4% Stock price decreasing 4.3% Stock price increasing
 
UCB 70.30 -6.7% Stock price decreasing -8.3% Stock price decreasing -7.8% Stock price decreasing -3.6% Stock price decreasing 7.7% Stock price increasing -1.4% Stock price decreasing
 
Roche Hldg Sp.Adr 1/8 28.54 -3.7% Stock price decreasing -3.7% Stock price decreasing 1.4% Stock price increasing 8.7% Stock price increasing 26.4% Stock price increasing 10.5% Stock price increasing
 
Sanofi SA ADR 1/2/EO 2 35.80 -4.3% Stock price decreasing -8.2% Stock price decreasing -0.6% Stock price decreasing -6.8% Stock price decreasing 9.8% Stock price increasing -2.2% Stock price decreasing
 
Teva Pharmaceutical Industries.. 14.36 -0.1% Stock price decreasing -15.9% Stock price decreasing -23.7% Stock price decreasing -33.0% Stock price decreasing -19.4% Stock price decreasing -6.9% Stock price decreasing

Company profile

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Tysabri and Tecfidera. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.

Peers

Instruments Last Change  
Abbott Labor.. 73.92 1.4% Stock price increasing
Bristol-Myer.. 45.52 -0.6% Stock price decreasing
Johnson & Jo.. 137.52 -0.7% Stock price decreasing
Pfizer Inc 39.38 -1.3% Stock price decreasing
Amgen Inc 177.47 -2.7% Stock price decreasing
Novartis AG 76.41 -1.2% Stock price decreasing
GlaxoSmithKl.. 39.85 -0.3% Stock price decreasing
UCB 70.30 -1.4% Stock price decreasing
Roche Hldg S.. 28.54 -2.6% Stock price decreasing
100,100,100,100,100,0,0,0,0,0
Sanofi SA AD.. 35.80 -2.7% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
Teva Pharmac.. 14.36 1.0% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 April 2019 09:59:27
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB1 - 2019-04-21 10:59:27 - 2019-04-21 09:59:27 - 1000 - Website: OKAY